SCHEMBL19632141

SCHEMBL19632141

CCN(C)CCN(CCCNC(N)=O)C(C)=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.34
ALDH1A1 P00352 1/20 0.33
KDM5A P29375 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
CHEK1 O14757 1/20 0.33
DAPK3 O43293 1/20 0.33
ROCK2 O75116 1/20 0.33
CHEK2 O96017 1/20 0.33
PRKCG P05129 1/20 0.33
CDK1 P06493 1/20 0.33
PIM1 P11309 1/20 0.33
RPS6KB1 P23443 1/20 0.33
CDK2 P24941 1/20 0.33
AKT1 P31749 1/20 0.33
AKT2 P31751 1/20 0.33
MAPKAPK2 P49137 1/20 0.33
RPS6KA3 P51812 1/20 0.33
NEK2 P51955 1/20 0.33
LIMK1 P53667 1/20 0.33
CDK5 Q00535 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15223813 0.87 KDM4E (0.40) DNM1KDM4EPAOXUSP2LMNA
SCHEMBL9601872 0.86 KDM5A (0.42) DNM1ALDH1A1KDM5AKDM4CCHEK1
SCHEMBL15223811 0.80 KDM5A (0.37) KDM5AKDM4CUSP2LMNA
SCHEMBL7763881 0.77 CHEK1 (0.42) DNM1CHEK1DAPK3ROCK2CHEK2
SCHEMBL15223873 0.76 DNM1 (0.35) DNM1ALDH1A1CHEK1KDM4EPAOX
SCHEMBL15830212 0.73 KDM4E (0.54) DNM1ALDH1A1KDM5AKDM4CKDM4E
SCHEMBL9729528 0.73 ALDH1A1 (0.56) ALDH1A1KDM4EPAOXMAPK1LMNA
SCHEMBL186589 0.73 DNM1 (0.52) DNM1ALDH1A1KDM4EPAOXLMNA
SCHEMBL12244766 0.73 KDM4E (0.58) ALDH1A1KDM4EPAOXCA14MAPK1
SCHEMBL19400586 0.73 CA12 (0.43) ALDH1A1KDM5AKDM4CCA14USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170333567-A1 Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers SYNTARGA BV (NL) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170333567-A1 Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers PCNA, DCLRE1A, CDC5L DNM1 1055/4885ALDH1A1 2514/4885KDM5A 189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.